Review on Cost of Anti-Glaucoma Formulation Available in India
Tarang R. Bhatt1*
and Dharmesh K. Golwala21Faculty of Pharmaceutical Science, C. U. Shah University, Wadhwan, Surendranagar, Gujarat, India.
2Department of Pharmacy, Shankersinh Vaghela Bapu, Institute of Pharmacy, Vasan, Gandhinagar, Gujarat, India.
Corresponding Author e-mail: tarang.bhatt@gmail.com
Abstract: The objective of the present work was to determine cost per annum of various glaucoma formulation to patients and plot changes in trends of cost these formulations over years. Main purpose of this study is to provide patients and health care providers with calculated yearly costs of topical glaucoma medications in India. A price per ml model was used to eradicate difference due to pack size of formulation of different brands. And average prices per ml of all studied brands were used to present data of particular drug formulation. Daily recommended drops were also taken into consideration to obtain cost of formulation to patient per year. And results indicated that cost of glaucoma treatment in India per annum to patient varied from as low as 193.3 INR to as high as 6616.72 INR in year 2015, quite similar to that in 2005 wherein cost per annum to patient varied from 191.55 INR to 5879.12 INR. Beta blockers were reported to be the most economical group of glaucoma medications while prostaglandin analogues and its combinations were reported to be expensive group of glaucoma medications. And the study concluded that cost of glaucoma drug therapy varies from few hundred to several thousand rupees in India. And although price per annum of glaucoma medication in India remains to be significantly less compared to other developed countries, steep rising cost first line drugs like timolol maleate over the years forecasts risings concern to patient in India.
Keywords: Cost of medications; Beta Blocker; Glaucoma; Prostaglandins; Timolol Maleate Back to TOC